Academic Journal
Phase 1b study of the anti-CD38 antibody mezagitamab in patients with relapsed/refractory multiple myeloma
| العنوان: | Phase 1b study of the anti-CD38 antibody mezagitamab in patients with relapsed/refractory multiple myeloma |
|---|---|
| المؤلفون: | Krishnan, Amrita Y., Patel, Krina K., Mohan, Meera, Jagannath, Sundar, Niesvizky, Ruben, Silbermann, Rebecca W., Yu, Ziji, Long, Tao, McDonnell, Scott R. P., Berg, Deborah, Stockerl-Goldstein, Keith E. |
| المساهمون: | Takeda Pharmaceuticals USA Inc |
| المصدر: | Blood Neoplasia ; volume 1, issue 4, page 100043 ; ISSN 2950-3280 |
| بيانات النشر: | Elsevier BV |
| سنة النشر: | 2024 |
| المجموعة: | ScienceDirect (Elsevier - Open Access Articles via Crossref) |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| DOI: | 10.1016/j.bneo.2024.100043 |
| الاتاحة: | https://doi.org/10.1016/j.bneo.2024.100043 https://api.elsevier.com/content/article/PII:S2950328024000438?httpAccept=text/xml https://api.elsevier.com/content/article/PII:S2950328024000438?httpAccept=text/plain |
| Rights: | https://www.elsevier.com/tdm/userlicense/1.0/ ; https://www.elsevier.com/legal/tdmrep-license ; http://creativecommons.org/licenses/by-nc-nd/4.0/ |
| رقم الانضمام: | edsbas.E6DCB260 |
| قاعدة البيانات: | BASE |
| DOI: | 10.1016/j.bneo.2024.100043 |
|---|